These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16279262)

  • 1. Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality.
    Creutzberg EC
    Chron Respir Dis; 2004; 1(2):79-81. PubMed ID: 16279262
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled corticosteroids and mortality in COPD.
    Sin DD;
    Thorax; 2006 Oct; 61(10):918. PubMed ID: 17063568
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled corticosteroids and mortality in COPD: are we there yet?
    Stirling R
    Thorax; 2006 Aug; 61(8):735. PubMed ID: 16877693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhaled corticosteroid therapy: a treatment with multiple impacts].
    Devillier PH
    Rev Pneumol Clin; 2005 Jun; 61 Spec No 1():30-3. PubMed ID: 16208255
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled corticosteroids and mortality in COPD.
    Omron E
    Chest; 2007 Mar; 131(3):939; author reply 940. PubMed ID: 17380589
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids in COPD and mortality: inaccuracies?
    Suissa S
    Am J Respir Crit Care Med; 2004 May; 169(10):1165-6; author reply 1166. PubMed ID: 15132963
    [No Abstract]   [Full Text] [Related]  

  • 8. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
    Marquis K; Debigaré R; Lacasse Y; LeBlanc P; Jobin J; Carrier G; Maltais F
    Am J Respir Crit Care Med; 2002 Sep; 166(6):809-13. PubMed ID: 12231489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.
    Cilli A; Erdem H; Karakurt Z; Turkan H; Yazicioglu-Mocin O; Adiguzel N; Gungor G; Bilge U; Tasci C; Yilmaz G; Oncul O; Dogan-Celik A; Erdemli O; Oztoprak N; Samur AA; Tomak Y; Inan A; Karaboga B; Tok D; Temur S; Oksuz H; Senturk O; Buyukkocak U; Yilmaz-Karadag F; Ozcengiz D; Karakas A; Savasci U; Ozgen-Alpaydın A; Kilic E; Elaldi N; Bilgic H
    J Crit Care; 2013 Dec; 28(6):975-9. PubMed ID: 24075301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease.
    Mador MJ
    Am J Respir Crit Care Med; 2002 Sep; 166(6):787-9. PubMed ID: 12231484
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Wood-Baker R; Walters J; Walters EH
    Respir Med; 2007 Mar; 101(3):371-7. PubMed ID: 16962307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease].
    Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist A; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA
    Rev Port Pneumol; 2005; 11(6):603-7. PubMed ID: 16518885
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhaled steroids and COPD mortality: limitation of epidemiological analysis of databases].
    Gillissen A; Lewis M; Worth H
    Pneumologie; 2003 Nov; 57(11):639-42. PubMed ID: 14618505
    [No Abstract]   [Full Text] [Related]  

  • 15. BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy.
    Ringbaek TJ; Viskum K; Lange P
    Chron Respir Dis; 2004; 1(2):71-8. PubMed ID: 16279261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids and mortality in COPD.
    Netzer G
    Chest; 2007 Mar; 131(3):939; author reply 940. PubMed ID: 17356119
    [No Abstract]   [Full Text] [Related]  

  • 17. COPD exacerbations: 5 days of corticosteroid therapy.
    Prescrire Int; 2014 Oct; 23(153):246-7. PubMed ID: 25964977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO; Leuenberger P
    Rev Med Suisse; 2005 Nov; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic steroids in COPD-the beauty and the beast.
    Vogelmeier CF
    Respir Res; 2014 Apr; 15(1):38. PubMed ID: 24708470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.